Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

The Delaware Comprehensive Sickle Cell Research Center

Award Number: P30GM165286
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/15/2026
PERIOD OF PERFORMANCE END DATE: 05/31/2031

Group Awards By:

View Award Description

The Delaware Comprehensive Sickle Cell Research Center - PROJECT SUMMARY (Overall) The Delaware Comprehensive Sickle Cell Research Center (DE SCD COBRE) is a biomedical research center of excellence that has established itself as a comprehensive center for the care of people with sickle cell disease. During COBRE Phase 1 and Phase 2 funding, the DE SCD COBRE successfully developed multiple early career investigators to complete translational, clinical and implementation science research. The successful recruitment of sickle cell researchers provided additional experience to the Center to facilitate the utilization of the matrix mentoring model for development of investigators across multiple disciplines with an interest in improving the care of people with sickle cell disease. Total funding bought to the state of Delaware from COBRE Phase 1 and Phase 2 research development now exceeds $69 million, including a large philanthropic gift to further strengthen research in cancer and blood disorders at Nemours Children’s Hospital in Delaware. During Phase 3 funding, we will continue to integrate with other Institutional Development Awards (IDeA) state programs, including the Delaware IDeA Network of Biomedical Research Excellence (INBRE) and the Delaware ACCEL Clinical and Translational Research (CTR) program. The Center will also continue to integrate with the growing research infrastructure at Nemours Children’s Hospital to help facilitate sustainability after the completion of COBRE Phase 3 funding. The successful recruitment and development of sickle cell researchers, continued robust implementation of the pilot project program, and efficient utilization of the Clinical Research and Data Informatics Core will lead to the financial sustainability of a comprehensive sickle cell center that both innovates in sickle cell care and delivers the highest quality care to people with sickle cell disease. Central to all aspects of the Delaware Sickle Cell Research Program is the overarching hypothesis that effective management of a common, congenital, multi-system disease requires comprehensive investigations spanning the biological and medical factors that impact both the severity of the disease and the efficacy of interventions.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $1,140,000 )
2026	2026	THE NEMOURS FOUNDATION	1600 ROCKLAND RD	WILMINGTON	DE	19803	NEW CASTLE	USA	Biomedical Research and Research Training	000	1	8/11/2026	NEW	$1,140,000
														Subtotal = $1,140,000

Grand Total All Awards = $1,140,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The Delaware Comprehensive Sickle Cell Research Center

Award Number: P30GM165286

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/15/2026

PERIOD OF PERFORMANCE END DATE: 05/31/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer